Sysmex (OTCMKTS:SSMXY) Sees Unusually-High Trading Volume – Here’s Why

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY – Get Free Report) saw an uptick in trading volume on Wednesday. Approximately 333,378 shares were traded during mid-day trading, an increase of 74% from the previous session’s volume of 191,515 shares. The stock last traded at $11.88 and had previously closed at $11.91.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Sysmex from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold”.

Check Out Our Latest Stock Report on SSMXY

Sysmex Price Performance

The firm has a 50-day moving average price of $11.77 and a 200 day moving average price of $9.94. The stock has a market capitalization of $7.45 billion, a P/E ratio of 28.17 and a beta of 1.18. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.53 and a current ratio of 3.40.

Sysmex (OTCMKTS:SSMXY – Get Free Report) last released its earnings results on Friday, August 7th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.07 by $0.02. The company had revenue of $825.85 million for the quarter, compared to analyst estimates of $741.67 million. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. On average, analysts expect that Sysmex Corporation ADR will post 0.41 EPS for the current year.

Sysmex Company Profile

(Get Free Report)

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes in vitro diagnostic products and laboratory solutions. The company is best known for its automated hematology analyzers, which are used to examine blood cells, along with related reagents, software and support services.

Its product portfolio also includes systems for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory automation and information-management solutions.

Further Reading

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.